Read + Share
Seufferlein T, Lausser L, Stein A, Arnold D, et al. Prediction of resistance to bevacizumab plus FOLFOX in metastatic colorectal
cancer-Results of the prospective multicenter PERMAD trial. PLoS One 2024;19:e0304324.
PMID: 38875244
|
 |
|
Seufferlein T, Lausser L, Stein A, Arnold D, et al. Prediction of resistance to bevacizumab plus FOLFOX in metastatic colorectal
cancer-Results of the prospective multicenter PERMAD trial. PLoS One 2024;19:e0304324.
PMID: 38875244
|
|
|
|